NO140824C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7alfa-hydroxy-oestratriener - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7alfa-hydroxy-oestratriener

Info

Publication number: NO140824C
Authority: NO; Norway
Prior art keywords: oestratriens; 7alfa; analogical; hydroxy; procedures
Prior art date: 1974-10-14

Application number

NO753455A

Other languages

English (en)

Other versions

NO140824B (no

NO753455L (no

Inventor

Karl Petzoldt

Hans-Joerg Vidic

Klaus Prezewowsky

Yukishige Nishino

Rudolf Wiechert

Henry Laurent

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1974-10-14

Filing date

1975-10-13

Publication date

1979-11-21

1974-10-14 Priority claimed from DE2449327A external-priority patent/DE2449327C2/de

1975-08-08 Priority claimed from DE19752535997 external-priority patent/DE2535997A1/de

1975-10-13 Application filed by Schering Ag filed Critical Schering Ag

1976-04-20 Publication of NO753455L publication Critical patent/NO753455L/no

1979-08-13 Publication of NO140824B publication Critical patent/NO140824B/no

1979-11-21 Publication of NO140824C publication Critical patent/NO140824C/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0096—Alkynyl derivatives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
- Y10S435/912—Absidia
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
- Y10S435/913—Aspergillus
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
- Y10S435/939—Rhizopus

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

NO753455A 1974-10-14 1975-10-13 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7alfa-hydroxy-oestratriener NO140824C (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE2449327A DE2449327C2 (de)	1974-10-14	1974-10-14	7 α-Hydroxy-östradiole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE19752535997 DE2535997A1 (de)	1975-08-08	1975-08-08	7-hydroxy-oestradiole

Publications (3)

Publication Number	Publication Date
NO753455L NO753455L (no)	1976-04-20
NO140824B NO140824B (no)	1979-08-13
NO140824C true NO140824C (no)	1979-11-21

Family

ID=25767825

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO753455A NO140824C (no)	1974-10-14	1975-10-13	Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7alfa-hydroxy-oestratriener

Country Status (23)

Country	Link
US (1)	US4011314A (no)
JP (1)	JPS5165747A (no)
AT (1)	AT348695B (no)
CA (1)	CA1054143A (no)
CH (2)	CH619240A5 (no)
CS (2)	CS205009B2 (no)
DD (1)	DD125588A5 (no)
DK (1)	DK135378C (no)
ES (1)	ES441784A1 (no)
FI (1)	FI54603C (no)
FR (1)	FR2287908A1 (no)
GB (1)	GB1528796A (no)
HU (1)	HU176715B (no)
IE (1)	IE42167B1 (no)
IL (1)	IL48276A (no)
NL (1)	NL7512041A (no)
NO (1)	NO140824C (no)
NZ (1)	NZ178886A (no)
PH (1)	PH13802A (no)
PL (2)	PL101461B1 (no)
SE (1)	SE405254B (no)
SU (2)	SU676170A3 (no)
YU (2)	YU243975A (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8327256D0 (en) *	1983-10-12	1983-11-16	Ici Plc	Steroid derivatives
DE3741800A1 (de) *	1987-12-07	1989-06-15	Schering Ag	17-halogenmethylen-estratriene
US5861431A (en) *	1995-06-07	1999-01-19	Iotek, Inc.	Incontinence treatment
AU716503B2 (en)	1996-04-09	2000-02-24	Btg International Limited	Neurosteroids
PT1955700E (pt)	1999-09-30	2011-05-04	Harbor Biosciences Inc	Tratamento terap?utico de doen?as associadas ao receptor de androg?nios
GB0003524D0 (en) *	2000-02-15	2000-04-05	Btg Int Ltd	Cytoprotective steroids (II)
GB2363983A (en) *	2000-06-29	2002-01-16	Hunter Fleming Ltd	Protection against neuronal damage using 7-hydroxyepiandrosterone
SI1624878T1 (sl) *	2003-05-22	2007-02-28	Pantarhei Bioscience Bv	Uporaba sestavkov, ki obsegajo estrogensko komponento, za zdravljenje in preprecevanje muskuloskeletne bolecine
GB0403889D0 (en) *	2004-02-21	2004-03-24	Univ Edinburgh	Uses of er-beta modulators
US7910755B2 (en)	2004-09-29	2011-03-22	Harbor Biosciences, Inc.	Stem cell expansion and uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3115444A (en) *	1962-01-22	1963-12-24	Olin Mathieson	Process for microbial hydroxylation of steroids containing aromatic alpha-rings

1975
- 1975-09-29 YU YU02439/75A patent/YU243975A/xx unknown
- 1975-09-30 DK DK439975A patent/DK135378C/da active
- 1975-10-06 CS CS756759A patent/CS205009B2/cs unknown
- 1975-10-06 CS CS756759A patent/CS205010B2/cs unknown
- 1975-10-07 NZ NZ178886A patent/NZ178886A/xx unknown
- 1975-10-09 US US05/621,136 patent/US4011314A/en not_active Expired - Lifetime
- 1975-10-10 SU SU752179006A patent/SU676170A3/ru active
- 1975-10-10 IL IL48276A patent/IL48276A/xx unknown
- 1975-10-10 AT AT775475A patent/AT348695B/de not_active IP Right Cessation
- 1975-10-10 DD DD188799A patent/DD125588A5/xx unknown
- 1975-10-11 PL PL1975183926A patent/PL101461B1/pl unknown
- 1975-10-11 PL PL1975206306A patent/PL103989B1/pl unknown
- 1975-10-13 PH PH18192A patent/PH13802A/en unknown
- 1975-10-13 FI FI752836A patent/FI54603C/fi not_active IP Right Cessation
- 1975-10-13 GB GB41798/75A patent/GB1528796A/en not_active Expired
- 1975-10-13 HU HU75SCHE540A patent/HU176715B/hu unknown
- 1975-10-13 SE SE7511438A patent/SE405254B/xx unknown
- 1975-10-13 NO NO753455A patent/NO140824C/no unknown
- 1975-10-14 NL NL7512041A patent/NL7512041A/xx not_active Application Discontinuation
- 1975-10-14 CA CA237,554A patent/CA1054143A/en not_active Expired
- 1975-10-14 JP JP50123743A patent/JPS5165747A/ja active Pending
- 1975-10-14 ES ES441784A patent/ES441784A1/es not_active Expired
- 1975-10-14 FR FR7531364A patent/FR2287908A1/fr active Granted
- 1975-10-14 CH CH1332375A patent/CH619240A5/de not_active IP Right Cessation
- 1975-10-14 IE IE2233/75A patent/IE42167B1/en unknown
1976
- 1976-09-27 SU SU2179006A patent/SU677666A1/ru active
1979
- 1979-10-31 CH CH977879A patent/CH619268A5/de not_active IP Right Cessation
1981
- 1981-12-15 YU YU02942/81A patent/YU294281A/xx unknown

Also Published As

Publication number	Publication date
YU294281A (en)	1982-06-30
ES441784A1 (es)	1977-04-01
AT348695B (de)	1979-02-26
PL103989B1 (pl)	1979-07-31
FI54603C (fi)	1979-01-10
IL48276A0 (en)	1975-12-31
CS205009B2 (en)	1981-04-30
NZ178886A (en)	1978-04-28
FI752836A (no)	1976-04-15
SE7511438L (sv)	1976-04-15
CH619268A5 (no)	1980-09-15
YU243975A (en)	1982-06-30
FR2287908A1 (fr)	1976-05-14
DK439975A (da)	1976-04-15
DK135378B (da)	1977-04-18
HU176715B (en)	1981-04-28
SE405254B (sv)	1978-11-27
AU8571075A (en)	1977-04-21
CA1054143A (en)	1979-05-08
PH13802A (en)	1980-10-01
FI54603B (fi)	1978-09-29
CH619240A5 (no)	1980-09-15
SU677666A3 (en)	1981-11-30
PL101461B1 (pl)	1978-12-30
US4011314A (en)	1977-03-08
FR2287908B1 (no)	1980-04-30
NO140824B (no)	1979-08-13
IE42167B1 (en)	1980-06-18
NO753455L (no)	1976-04-20
SU677666A1 (ru)	1981-11-30
ATA775475A (de)	1978-07-15
SU676170A3 (ru)	1979-07-25
DD125588A5 (no)	1977-05-04
NL7512041A (nl)	1976-04-20
IE42167L (en)	1976-04-14
CS205010B2 (en)	1981-04-30
DK135378C (da)	1977-10-03
IL48276A (en)	1979-03-12
JPS5165747A (en)	1976-06-07
GB1528796A (en)	1978-10-18

Similar Documents

Publication	Publication Date	Title
NO157933C (no)	1988-06-15	Analogifremgangsmaate for fremstilling av terapeutisk virksomme cefemforbindelser.
NO145691C (no)	1982-05-12	Analogifremgangsmaate til fremstilling av terapeutisk virksomme decapeptidamider
NO142034C (no)	1980-06-18	Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoletere.
NO137440C (no)	1978-03-01	Analogifremgangsmaate for fremstilling av terapeutisk aktive pleuromutiliner
NO151040C (no)	1985-01-30	Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner
NO140058C (no)	1979-07-04	Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater
NO138999C (no)	1978-12-20	Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner
NO140824C (no)	1979-11-21	Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7alfa-hydroxy-oestratriener
NO781879L (no)	1978-12-01	Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO140596C (no)	1979-10-03	Analogifremgangsmaate for fremstilling av en terapeutisk aktive hydroksyalkylxantiner
NO140670C (no)	1979-10-17	Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolodiazepinderivater
NO137858C (no)	1978-05-10	Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner
NO144108C (no)	1981-06-24	Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-benzylpiperid-4-yl)-benzamider
NO137894C (no)	1978-05-24	Analogifremgangsmaate for fremstilling av farmakologisk aktive amidoksimer
NO139733C (no)	1979-05-02	Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av metylamin
NO138251C (no)	1978-08-02	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzylaminer
NO140299C (no)	1979-08-08	Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-5-aminoalkyl-4-oksazolin-2-oner
SE414029B (sv)	1980-07-07	Forfarande for framstellning av terapeutiskt aktiva fentiazinderivat
NO138285C (no)	1978-08-09	Analogifremgangsmaate ved fremstilling av terapeutisk aktive lincomycinderivater
NO144741C (no)	1981-11-18	Analogifremgangsmaate for fremstilling av terapeutisk aktive tiopyrano-pyrazoler
NO137695C (no)	1978-04-05	Analogifremgangsmaate for fremstilling av terapeutisk aktive n-tienylmetyl-heterocykliske forbindelser
NO140007C (no)	1979-06-20	Analogifremgangsmaate ved fremstilling av terapeutisk aktive indolcarboxylsyrer
NO146136C (no)	1982-08-04	Analogifremgangsmaate for fremstilling av terapeutisk aktive indanderivater
NO140598C (no)	1979-10-03	Analogifremgangsmaate ved fremstilling av terapeutisk aktive glukosederivater
NO141162C (no)	1980-01-23	Analogifremgangsmaate til fremstilling av terapeutisk aktive 4-okso-2-imidazolidinyliden-urinstoffer